Products
A platform and a separate practice.
Responder Atlas is our platform, built on public pharmacogenomic data. Trial Enrichment Strategy is a separate offering — the same geometric method run privately on a client's patient data. One engine, two homes.
Platform
Responder Atlas.
Query the Atlas by molecule for indication signal, responder structure, and candidate biomarkers. Starts with DepMap/PRISM; expands to more public sources over time. Hypothesis-generating triage — not clinical prediction.
Applications
Available
Indication Lite (free)
The free structure-to-indication signal — a ranked map across 17 cancer tissue types.
Available
Indication Full (paid report)
The paid per-compound report — responder subpopulations and candidate biomarkers.
Coming soon · in development
Biomarker SaaS
Query the Atlas by biomarker or gene signature to find compounds with matching responder structure. In development — early-access enquiries welcome.
Separate · patient data
Trial Enrichment Strategy.
Unsupervised geometric analysis of tumor gene-expression data, run privately on your cohort. The published-preprint result on JAVELIN Renal 101 sits at 82.0% out-of-sample accuracy — see /trial-enrichment.
Continuous access
Discover.
Continuous access — for teams running triage more than once.